Cardio Diagnostics Holdings, Inc.
CDIO
Rank in Stocks
#30363
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to... Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Share Price
$1.82
Last synced: 2026-11-09
Market Cap
$5.39M
Change (1 day)
10.24%
Change (1 year)
-52.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cardio Diagnostics Holdings, Inc. (CDIO)
Category
Healthcare
EPS for Cardio Diagnostics Holdings, Inc. (CDIO)
EPS as of September 2026 TTM: $-2.53
According to Cardio Diagnostics Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $-2.53. At the end of 2025 the company had an EPS of $-3.71, an increase over its 2024 EPS of $-9.30.
EPS history for Cardio Diagnostics Holdings, Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.53 | -31.81% |
| 2025 | $-3.71 | -60.11% |
| 2024 | $-9.30 | -53.03% |
| 2023 | $-19.80 | -56.29% |
| 2022 | $-45.30 | 2,211.22% |
| 2021 | $-1.96 | 2,981.76% |
| 2020 | $-0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -718.97% |
US
|
|
| $-7.07 | 179.45% |
US
|
|
| $-5.29 | 109.09% |
AU
|
|
| $12.88 | -609.09% |
BE
|
|
| $21.56 | -952.17% |
NL
|
Questions about Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS)
What is Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS)?
Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $-2.53, as of Sep 2026.
What was Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) was $-3.71, compared with $-9.30 in 2024.
How has Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.06) and lowest in 2022 ($-45.30).
How does Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
Cardio Diagnostics Holdings, Inc.'s earnings per share (EPS) ($-2.53) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.